Progress of ulcerative colitis patients during the COVID-19 pandemic

doi:10.12998/wjcc.v11.i23.5462

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 23

This Article

(147)

(152)

(0)

(7)

(2)

(3580)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Aug 16, 2023; 11(23): 5462-5467
Published online Aug 16, 2023. doi: 10.12998/wjcc.v11.i23.5462

Table 2 Pharmacotherapies used for the 2020, 2021, and 2022 groups, n (%)

	2020 (n = 289)	2021 (n = 279)	2022 (n = 268)
5-ASA	165 (57.0)	158 (56.6)	151 (56.3)
AZA or 6-MP	35 (12.1)	32 (11.4)	33 (12.3)
IFX	36 (12.4)	35 (12.5)	33(12.3)
ADA	26 (8.9)	26 (9.3)	26 (9.7)
GLM	9 (3.1)	9 (3.2)	7 (2.6)
VDZ	0 (0)	1 (0.3)	1 (0.3)
UST	0 (0)	1 (0.3)	1 (0.3)
TFN	2 (0.6)	2 (0.7)	3 (1.1)
TF	8 (2.7)	8 (2.8)	7 (2.6)
IR	5 (1.7)	5 (1.7)	4 (1.0)
PSL	1 (0.3)	0 (0)	1 (0.3)
CHM	1 (0.3)	1 (0.3)	1 (0.3)
ND	1 (0.3)	1 (0.3)	0 (0)

5-ASA: Aminosalicylic acid; AZA: Azathioprine; 6-MP: Mercapton; IFX: Infliximab; ADA: Adalimumab; GLM: Golimumab; UST: Ustekinumab; TFN: Tofacitinib; VDZ: Vedolizmab; TF: Topical formulation; IR: Intestinal regulator; PSL: Prednisolone; CHM: Chinese herbal medicine; ND: No drug.

Full Size Table

Citation: Suda T, Takahashi M, Katayama Y, Soga K, Kobori I, Kusano Y, Tamano M. Progress of ulcerative colitis patients during the COVID-19 pandemic. World J Clin Cases 2023; 11(23): 5462-5467
URL: https://www.wjgnet.com/2307-8960/full/v11/i23/5462.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i23.5462

Suda T, Takahashi M, Katayama Y, Soga K, Kobori I, Kusano Y, Tamano M. Progress of ulcerative colitis patients during the COVID-19 pandemic. World J Clin Cases 2023; 11(23): 5462-5467 [PMID: 37637693 DOI: 10.12998/wjcc.v11.i23.5462]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.